Singapore Medicinal Mushroom Market Size & Outlook, 2026-2034

Singapore Medicinal Mushroom Market Insights

As per Deep Market Insights insights, the Singapore Medicinal Mushroom Market stood at USD 268.76 Million in 2025 and is anticipated to grow to USD 829.89 Million by 2034.
The Singapore market is expected to advance at a CAGR of 13.34% from 2026 through 2034.
In 2025, Reishi accounted for the highest share of the By Type market size.
During the forecast period, Reishi is set to register the highest growth, making it the most lucrative By Type segment.

In 2025, Singapore represented 0.31% of the overall global Medicinal Mushroom Market size.
United States is projected to lead the global Medicinal Mushroom Market size by 2034.
Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2034.
Singapore is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 829.53 Million by 2034.

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 268.76 Million
Market Size In 2034	USD 829.89 Million
Largest segment	Reishi
Units	Revenue in USD Million
CAGR	13.34% (2026-2034)
Segmnetation Covered
By Type	Reishi Chaga Cordyceps Lion’s mane
By Form	Powder Capsules Extracts Whole dried
By Application	Nutraceuticals Pharmaceuticals Functional foods Beverages
By End User	Healthcare sector Food industry Consumers Research institutes
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

By Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Reishi	XX.x	XX.x	XX.x	108.34	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Chaga	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Cordyceps	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Lion’s mane	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Form	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Powder	XX.x	XX.x	XX.x	107.94	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Capsules	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Extracts	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Whole dried	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Nutraceuticals	XX.x	XX.x	XX.x	108.29	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pharmaceuticals	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Functional foods	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Beverages	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By End User	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Healthcare sector	XX.x	XX.x	XX.x	111.03	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Food industry	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Consumers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Research institutes	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x